Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test

• Tim Waterboer,
• Nicole Brenner,
• Jens P. Klussmann,
• Paul Brennan,
• Ulrike Wieland,
• Hilary A. Robbins

Affiliations

Tim Waterboer

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Corresponding author.

Nicole Brenner

Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Jens P. Klussmann

Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty, University of Cologne, Cologne, Germany

Paul Brennan

Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France

Ulrike Wieland

National Reference Center for Papilloma- and Polyomaviruses, University of Cologne, Cologne, Germany

Hilary A. Robbins

Genetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France